Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 7 studies | 32% ± 20% | |
| neuron | 4 studies | 20% ± 2% | |
| endothelial cell | 4 studies | 24% ± 6% | |
| GABAergic neuron | 4 studies | 35% ± 17% | |
| interneuron | 4 studies | 28% ± 16% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 5 studies | 27% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 97% | 5426.55 | 2558 / 2642 | 98% | 18.08 | 693 / 705 |
| prostate | 75% | 909.61 | 184 / 245 | 99% | 13.88 | 498 / 502 |
| skin | 72% | 4032.01 | 1302 / 1809 | 94% | 12.97 | 446 / 472 |
| adrenal gland | 69% | 673.38 | 178 / 258 | 97% | 30.30 | 224 / 230 |
| esophagus | 50% | 787.18 | 717 / 1445 | 91% | 10.08 | 167 / 183 |
| intestine | 43% | 513.88 | 415 / 966 | 94% | 12.39 | 497 / 527 |
| breast | 35% | 295.61 | 159 / 459 | 87% | 8.87 | 978 / 1118 |
| pancreas | 30% | 233.51 | 98 / 328 | 81% | 6.88 | 144 / 178 |
| uterus | 16% | 136.25 | 27 / 170 | 94% | 14.06 | 433 / 459 |
| thymus | 46% | 373.64 | 303 / 653 | 61% | 4.48 | 367 / 605 |
| lung | 27% | 230.30 | 154 / 578 | 80% | 7.50 | 924 / 1155 |
| ureter | 0% | 0 | 0 / 0 | 100% | 27.66 | 1 / 1 |
| stomach | 9% | 63.32 | 31 / 359 | 91% | 11.15 | 259 / 286 |
| tonsil | 0% | 0 | 0 / 0 | 98% | 14.58 | 44 / 45 |
| eye | 0% | 0 | 0 / 0 | 98% | 7.28 | 78 / 80 |
| bladder | 5% | 33.95 | 1 / 21 | 88% | 10.92 | 443 / 504 |
| kidney | 24% | 174.71 | 21 / 89 | 53% | 2.93 | 474 / 901 |
| ovary | 1% | 7.04 | 2 / 180 | 60% | 4.21 | 257 / 430 |
| lymph node | 0% | 0 | 0 / 0 | 59% | 3.27 | 17 / 29 |
| liver | 0% | 4.52 | 1 / 226 | 56% | 3.27 | 229 / 406 |
| spleen | 17% | 121.50 | 40 / 241 | 0% | 0 | 0 / 0 |
| heart | 14% | 104.07 | 122 / 861 | 0% | 0 | 0 / 0 |
| adipose | 9% | 72.22 | 111 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 2% | 22.43 | 29 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 0% | 8.53 | 4 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 2.52 | 3 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0050808 | Biological process | synapse organization |
| GO_0048172 | Biological process | regulation of short-term neuronal synaptic plasticity |
| GO_0016081 | Biological process | synaptic vesicle docking |
| GO_0007269 | Biological process | neurotransmitter secretion |
| GO_0098978 | Cellular component | glutamatergic synapse |
| GO_0048786 | Cellular component | presynaptic active zone |
| GO_0001669 | Cellular component | acrosomal vesicle |
| GO_0005829 | Cellular component | cytosol |
| GO_0098831 | Cellular component | presynaptic active zone cytoplasmic component |
| GO_0098875 | Cellular component | epididymosome |
| GO_0005515 | Molecular function | protein binding |
| Gene name | PPFIA3 |
| Protein name | Liprin-alpha-3 (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-3) (PTPRF-interacting protein alpha-3) PTPRF interacting protein alpha 3 |
| Synonyms | KIAA0654 |
| Description | FUNCTION: May regulate the disassembly of focal adhesions. May localize receptor-like tyrosine phosphatases type 2A at specific sites on the plasma membrane, possibly regulating their interaction with the extracellular environment and their association with substrates. . |
| Accessions | A0A0C4DGR8 O75145 ENST00000602848.5 R4GN36 ENST00000602897.1 ENST00000334186.9 [O75145-1] R4GNF1 ENST00000602509.5 ENST00000602351.5 [O75145-2] A0A0C4DGR7 ENST00000602655.5 |
